EN MÉMOIRE Prof. Jean-Jacques Cassiman


Prof Jean-Jacques Cassiman passed away on August 5 after a long battle against lung cancer. He was 79 years old. With this sad event, we lose a giant in the field. We all know his commitment and realizations within the domain of medical genetics, ranging from the development and implementation of DNA testing in the diagnostic lab and its use for historical and forensic investigations to his strong societal engagement where he fought for more attention for rare and genetic disorders. He has been key for the development of the Belgian Plan for Rare Disorders and was always in the forefront for promoting and advancing our field. 

He had an outspoken role in genetics at the international level. As the secretary-general of the European Society from 1993 to 1999, he professionalized the society and transformed it from a scientific society to a forum that also dealt with societal, legal and ethical aspects of genetics. Via different European projects, he has been a thriving force for the harmonization, validation and standardization in genetic testing. 

From 2010 on, he was the chair of Kom op tegen Kanker. The organization and its societal and political impact have considerably grown during these years.

Jean-Jacques was an excellent communicator and an example for many of us in how to explain in simple words the fascinating complexity of genetics to lay people: “he taught his people everything about DNA”… He was straight, inspiring, not afraid of giving his opinion, made things happen, loved progression but hated delays or postponements, and he had a fine sense of humor… The College for Genetics & Rare Diseases will miss him deeply and we want to express our condolences to his family, friends and all who were very dear to him.

EN MÉMOIRE Prof. Jean-Jacques Cassiman
La discrimination génétique? Pas acceptable.

La discrimination génétique? Pas acceptable.

La société européenne de génétique humaine met en garde contre l'utilisation abusive…

En savoir plus
Un «no deal Brexit» pourrait avoir un impact néfaste sur 4 millions de personnes atteintes d'une maladie rare

Un «no deal Brexit» pourrait avoir un impact néfaste sur 4 millions de personnes atteintes d'une maladie rare

Un groupe d'experts du Royaume-Uni, coordonné par Dr. Marc Tischowitz de l'Université…

En savoir plus
EN MÉMOIRE Gertjan B. van Ommen – 28 septembre 1947 – 7 novembre 2020

EN MÉMOIRE Gertjan B. van Ommen – 28 septembre 1947 – 7 novembre 2020

Le Collège de Génétique et Maladies Rares rapporte avec grand regret le décès de son…

En savoir plus
COVID-19: liste de priorités en génétique clinique

COVID-19: liste de priorités en génétique clinique

En concertation avec les autorités fédérales et en accord avec les associations professionnelles…

En savoir plus
Top